Evidence map›Paper›PMID 37378703›Full record

ArticleLasers in medical science2023

Zn(II) porphyrin-encapsulated MIL-101 for photodynamic therapy of breast cancer cells.

Samaneh Hashemi Ghoochani, Hasan Ali Hosseini, Zahra Sabouri, Mohammad Hasan Soheilifar, Hoda Keshmiri Neghab, Alireza Hashemzadeh, Mahin Velayati, Majid Darroudi

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Samaneh Hashemi GhoochaniChemistry Department, Payame Noor University, Tehran, 19395-4697, Iran.
Hasan Ali HosseiniChemistry Department, Payame Noor University, Tehran, 19395-4697, Iran.
Zahra SabouriDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Hasan SoheilifarDepartment of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Hoda Keshmiri NeghabDepartment of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Alireza HashemzadehDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahin VelayatiChemistry Department, Payame Noor University, Tehran, 19395-4697, Iran.
Majid DarroudiDepartment of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran. darroudim@mums.ac.ir.ORCID http://orcid.org/0000-0002-2624-7242
Payame Noor University · IRMashhad University of Medical Sciences · IRAcademic Center for Education, Culture and Research · IRUniversity of Neyshabur · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The photodynamic treatment is a non-aggressive and clinically accepted procedure for removing selected cancer cells with the activation of a photosensitizer agent at a specific light. In this study, the zinc porphyrin (Zn[TPP]) was prepared and encapsulated into the MIL-101 (Zn[TPP]@MIL-101). It was used in photodynamic therapy (PDT) against MCF-7 breast cancer cells under a red light-emitting diode. The structure, morphology, surface area, and compositional changes were investigated using conventional characterization methods including FTIR, FESEM, EDX, and BET analyses. The MTT assay was performed under light and dark conditions to explore the ability of Zn[TPP]@MIL-101 in PDT. The results have demonstrated the IC

Indexed as

Breast NeoplasmsPhotochemotherapyPorphyrinsCell Line, TumorFemaleHumansMetal-Organic FrameworksPhotosensitizing AgentsZincMetal-Organic FrameworksMIL-101Photosensitizing AgentsPorphyrinsZincBreast cancerMetal–organic frameworkPhotodynamic therapyPorphyrin

Identifiers

PMID37378703
OpenAlexW4382345000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.